TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Sat Nov 26

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 6:29 PM

Mon Nov 21

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 11:53 AM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 2:41 AM

Fri Nov 18

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 5:30 PM

Thu Nov 17

NL

Article

TMFBiologyFool published an article 4:20 PM

Better Buy: Juno Therapeutics vs. bluebird bio

A battle of two platform drugmakers.

Wed Nov 16

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 6:05 PM

Stock Advisor Boards Post

TMFBiologyFool posted to the Stock Advisor boards. 2:16 PM

Tue Nov 15

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 7:11 PM

Supernova Boards Post

TMFBiologyFool posted to the Supernova boards. 3:30 AM

Mon Nov 14

NL

Article

TMFBiologyFool published an article 3:55 PM

Why Celldex Therapeutics, Inc. Stock Jumped Higher Again Today

Seeming anything -- including preclinical data -- will spark shares of the beaten-down biotech.

NL

Article

TMFBiologyFool published an article 1:03 PM

Why Corbus Pharmaceuticals Holdings Inc. Skyrocketed Higher Today

Positive phase 2 data from the small biotech sends shares higher.

Fri Nov 11

NL

Article

TMFBiologyFool published an article 4:00 PM

Ionis Pharmaceuticals Inc Back in the Black (for Now)

The biotech produces positive earnings, but to stay there it's going to have to get some more drugs approved.

Rule Breakers article.

TMFBiologyFool published an update. 3:05 PM

Thu Nov 10

NL

Article

TMFBiologyFool published an article 2:41 PM

Emergent Biosolutions Inc Slimmed Down, Waiting on Contract

After shedding its biologics division, the biodefense specialist waits for final details of its contract with the U.S. government to sell its anthrax vaccine.

Rule Breakers article.

TMFBiologyFool published an update. 1:30 PM

Wed Nov 9

NL

Article

TMFBiologyFool published an article 3:38 PM

Why These Biotechs Are Soaring Today

Investors believe a Trump presidency is better for the biotech industry than a Clinton one would have been.

NL

Article

TMFBiologyFool published an article 2:40 PM

727.6 Million Reasons bluebird bio Inc. Has Time to Figure It Out

The biotech has enough cash to work out the problems with its gene therapy process.

NL

Article

TMFBiologyFool published an article 1:38 PM

Why These Biotechs Saw Double-Digit Gains Today

Investors re-evaluate biotechs' valuations now that Hilary Clinton won't be president.

Rule Breakers article.

TMFBiologyFool published an update. 1:19 PM

Tue Nov 8

NL

Article

TMFBiologyFool published an article 5:34 PM

Why Cempra Inc Fell Over the Last 2 Days

FDA uncertainty plagues the biotech's share price.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 84.21
Player Rank 11803 out of 74751
Score 535.00
Score Change Today +10.16
Accuracy 67.14%
Active Picks 71
Total Picks 215
Best Pick UNH (+307.47)
Worst Pick INCY (-973.06)
Average Score per Pick 2.49
Charms Earned 11
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1359
Recs Received 2133
People who have rec'd these posts 625
Recs to Posts Ratio (last 30 days) N/A
Threads Started 142
Threads Started Percentage 10.45 %
Most Frequent Board Motley Fool Supernova
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 57.03 %
Show TMFBiologyFool’s 10 Latest Posts